Saman­tha Du's Zai Lab inks sur­pris­ing re­search col­lab with Schrödinger for DNA dam­age drug

Head­ed by Saman­tha Du, Chi­nese on­col­o­gy spe­cial­ist Zai Lab has made no qualms about its ag­gres­sive in-li­cens­ing strat­e­gy to dri­ve West­ern drugs in­to re­gion­al mar­kets. That strat­e­gy has been prof­itable so far, but that doesn’t mean Du’s team isn’t will­ing to try some­thing new.

In a sur­pris­ing volte-face, Zai Lab has signed its name to a re­search col­lab­o­ra­tion with physics-based dis­cov­ery out­fit Schrödinger look­ing for an on­col­o­gy can­di­date tar­get­ing the DNA dam­age re­pair path­way, the part­ners said Wednes­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER